"Blue Chip" Private Placement April Dazzling &Nbsp; Gem Fell Sharply Lv Jun

April sunshine

Reporter statistics found that as of April 24th, unstructured sunshine private placement decreased by 0.8% in the past month, while the Shanghai Composite Index rose nearly 1% during the same period.

In the first 10 months of last month, a group of old private equity companies, such as the same assets, Kai Po assets and elite era, emerged.

But it is also an old private placement, but the performance of two "public offering" private equity fund managers is not satisfactory.

Lv Jun's calm

From the end of the first quarter to the present, there has been a big reshuffle in the private placement list.

In the first quarter of the year, the Huixin 1, which entered the first quarter results, ranked second in all sunshine private placement funds in the first month of 15% with a decrease of 15%.

Hong Yi 1, winning 1 phase and other first quarter advance funds, also in recent months have fallen the top list.

Blue chip private placement

In the past month, the gem index fell more than 10%, the SME board index fell by nearly 7%, and the Shanghai and Shenzhen 300 index did not rise or fall.

As of April 22, 2011, the 1 phase of Jun Fu rose by 15% in January and surpassed the 14% in Shanghai and Shenzhen 300 index in the same period.

Jun Fu 1 investment manager for Wang Jin, after ten years of securities research and 10 billion scale fund investment experience.

In terms of investment strategy, Jun Fu insists on the top-down strategy of stock selection. In stock selection, he pays attention to the evaluation of intrinsic value of enterprises and does not buy stocks that can not be valued.

Performance improved faster, and last year's poor performance of Jing Liang investment, Tongwei assets, Kai Po assets.

In 2010, Jing Liang 1 and Kai Bao 1 fell 23% and 18% respectively, becoming the worst performing two private placements, and in 2009, their net value had entered the top ten.

The recent recovery of these funds has benefited from the overall rise of the blue chip market.

Take Kai Po assets as an example, the company concentrated funds in blue chip stocks with large market value from 2008 to 2010.

Ye Youjian, an investment manager who worked in Xingye securities and Shenyin Wanguo, talked publicly about his investment style. He said publicly that "our logic is to insist on buying only large blue chips and large cap companies."

Li Chi, general manager of Tongwei asset in Shenzhen, is a typical undervalued board advocate.

In April 19th and April 25th, he issued separately the "high quality blue chips with high liquidity" without a positive premium. It will become history, and China's GEM stocks and value shares are on the road of value return. It even claims that the 1000 index of the gem index is probably the ten year's top.

At the top of the list, there are 2 familiar faces such as Ming Yuan and Lin Yuan.

In recent months, the rapid pformation of market hotspots has increased the difficulty for managers, and private equity has divergent views on market style conversion, leading to the differentiation of private monthly performance. The difference between the beginning and the end is nearly 31%.

Shang Cheng holds two small plates.

As of April 27th, the gem composite index closed at 943 points. Since its inception in June 1, 2010, it has dropped fourth points for 1000 times.

The decline of the gem has brought down many small and medium-sized private placements.

In the past month, the top three of the private placement fell by 1, 1 and 1 respectively.

In April, more obvious private-owned companies were still honest, new value and easy investment series, because of the stagflation of small cap stocks and the callbacks of pharmaceutical stocks.

The old private placement is still relatively large. With the two heavy stocks of the fund coming out, the operation ideas are looming.

At the end of the first quarter, Shangcheng emerged as the third largest shareholder in New Zealand.

Data show that Shangcheng bought 560 thousand new states in the first quarter of 2010 and added 220 thousand shares in the two quarter, and the number of shares has remained unchanged since then.

The new state is in the special chemical sector. Its main products are aluminum electrolytic capacitor chemicals, solid polymer capacitor chemicals, super capacitor electrolyte and lithium-ion battery electrolyte.

In the first quarter of 2011, the company achieved a net profit of 24 million 220 thousand yuan, but the ratio fell by 25%.

By the end of April 20th, the new NAV declined by 4% in recent months.

Another listed company is the small and medium-sized board stocks, and the 178 thousand and 800 stocks currently held are all in the fourth quarter of 2010.

Zhong Ye Da is a trading company and industrial dealer. The net profit of Zhong Ye DA in the first quarter of 2011 was 48 million yuan, an increase of 50%.

However, as of Shangcheng net value announcement, the stock fell 10% in recent months.

Although two GEM stocks fell with the gem index, but from the perspective of honest operation, the number of shares held by two stocks has remained unchanged, which fully reflects Xiao Hua's consistent adherence to value investing.

Calm heavy positions two GEM stocks low

The same is true of small and medium capitalization stocks, and easy investment is not so lucky.

In the first 20 months of the month, 5 of the private placement investors took part in the private placement of sunshine. The investment elite was calm A and the investment elite relaxed B down more than 10%. The 5 phase of calm growth, the 2 phase of calm medical treatment and the 3 phase of the relaxed domestic demand medical treatment, the decrease was 7% to 9%.

So far, at the end of the first quarter of easy investment, Baotuan has appeared in two GEM stocks.

Rip bio has been calmly treated in 2 and 5 phases, holding 270 thousand shares.

At the end of the first quarter, Rip's biological closing price was 30.98 yuan.

According to this estimate, the 2 phase of the calmly medical market is about 5 million 270 thousand yuan.

Taking the initial scale of the 2 phase 94 million 400 thousand yuan in a leisurely way, multiplied by the net value of 0.8944 yuan, it is concluded that the scale of the fund is currently about 84 million 400 thousand yuan.

It can be estimated that the proportion of the total assets of the 2 phase of the easy medical treatment is about 6%.

According to public information, Rip was listed in September 6, 2010, issuing 18 million 600 thousand shares and issuing price of 60 yuan.

As of April 26th, the stock revaluation price was 55.9 yuan, which has fallen by more than 20% this year, and its share price has reached a new low since the listing.

Another gem that is easy to hold is new open source.

Among them, the 90 thousand phase of the 5 phase of the easy growth was new in the first quarter of 2011. The 350 thousand shares of the 2 phase of the calm medical treatment were bought in the fourth quarter of 2010, and from this time on, the 3.9% largest shareholding ratio became the largest circulation shareholder of the new open source.

The new open source is in the special chemical sector. It is the largest PVP manufacturer in China and is mainly engaged in R & D, production and marketing of PVP products.

But in the boom of special chemical industry this year, the stock has gone straight, hitting a record low, and the price has dropped by 27% since its listing.

Up to now, the new open source dynamic price earnings ratio is still 77 times. In the first quarter of 2011, the company achieved a net profit of 5 million yuan, down 10.96% from the same period last year.

In the fourth quarter of last year, the pharmaceutical sector was in a downward trend, but Lv Jun said in the media interview at the end of the first quarter, "the pharmaceutical industry has many fine industries, and these sub sectors will rotate."